Comments
Loading...
NeuroSense Therapeutics (NRSN) Forecast
NewsEarningsNeuroSense Therapeutics (NRSN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNeuroSense Therapeutics (NASDAQ:NRSN) Stock Quotes, Forecast and News Summary
NeuroSense Therapeutics Stock (NASDAQ: NRSN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NeuroSense Therapeutics (NRSN) stock?
You can purchase shares of NeuroSense Therapeutics (NASDAQ:NRSN) through any online brokerage.
Who are NeuroSense Therapeutics (NRSN) competitors?
There are no as such competitors for NeuroSense Therapeutics.
What is the forecast, or price target, for NeuroSense Therapeutics (NRSN) stock?
NeuroSense Therapeutics has a consensus price target of $7.50.
What is the current price for NeuroSense Therapeutics (NRSN)?
The stock price for NeuroSense Therapeutics (NASDAQ: NRSN) is $1.13 last updated February 19, 2025 at 3:41 PM EST.
Does NeuroSense Therapeutics (NRSN) pay a dividend?
There are no upcoming dividends for NeuroSense Therapeutics.
When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?
NeuroSense Therapeutics’s Q4 earnings are confirmed for Friday, April 4, 2025.
Is NeuroSense Therapeutics (NRSN) going to split?
There is no upcoming split for NeuroSense Therapeutics.
What sector and industry does NeuroSense Therapeutics (NRSN) operate in?
NeuroSense Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.